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Abstract
Background: Grating-based x-ray dark-field and phase-contrast imaging allow extracting information about
refraction and small-angle scatter, beyond conventional attenuation. A step towards clinical translation has recently
been achieved, allowing further investigation on humans.
Methods: After the ethics committee approval, we scanned the full body of a human cadaver in anterior-posterior
orientation. Six measurements were stitched together to form the whole-body image. All radiographs were taken at
a three-grating large-object x-ray dark-field scanner, each lasting about 40 s. Signal intensities of different
anatomical regions were assessed. The magnitude of visibility reduction caused by beam hardening instead of
small-angle scatter was analysed using different phantom materials. Maximal effective dose was 0.3 mSv for the
abdomen.
Results: Combined attenuation and dark-field radiography are technically possible throughout a whole human
body. High signal levels were found in several bony structures, foreign materials, and the lung. Signal levels were
0.25 ± 0.13 (mean ± standard deviation) for the lungs, 0.08 ± 0.06 for the bones, 0.023 ± 0.019 for soft tissue, and
0.30 ± 0.02 for an antibiotic bead chain. We found that phantom materials, which do not produce small-angle
scatter, can generate a strong visibility reduction signal.
Conclusion: We acquired a whole-body x-ray dark-field radiograph of a human body in few minutes with an
effective dose in a clinical acceptable range. Our findings suggest that the observed visibility reduction in the bone
and metal is dominated by beam hardening and that the true dark-field signal in the lung is therefore much higher
than that of the bone.
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Key points
 We presented the first whole-body x-ray dark-field
images of a human body.
 In the used setup, dark-field signal of the bones orig-
inates mainly from beam hardening.
 Beam hardening correction methods are important
for medical applications of x-ray dark-field
radiography.
Background
Besides the x-ray attenuation, which is measured by con-
ventional x-ray imaging, wave-optical effects such as
refraction and small-angle scatter of x-rays occur on
interaction with matter.
X-ray phase-contrast imaging utilises a Talbot-Lau
interferometer to measure these effects. By placing three
gratings in the beam path of a conventional source,
intensity modulations are created from which the phase
and small-angle scatter information can be obtained.
Subsequently, attenuation, differential phase, and dark-
field images of a sample placed in the beam path can be
calculated form these recorded modulations [1–10]. The
dark-field image provides a measure for the magnitude
of small-angle x-ray scattering induced by a sample. The
correlation between dark-field signal and microscopic
sample parameters has been examined in detail [11–13].
A conventional source has a broad x-ray energy
spectrum, and thus, beam hardening occurs when meas-
uring thicker samples. This spectral change also affects
the dark-field measurement, as the dark-field signal is
highly dependent on the x-ray energy E [11, 13, 14].
Applications for this new imaging modality have been
found both in the context of basic research, non-
destructive testing, and medical diagnostics [15–29].
Concerning the latter, the first in vivo dark-field radio-
graph of a mouse revealed a high dark-field signal ori-
ginating from the lungs [30], which motivated a large
number of small animal studies as many pulmonary dis-
eases are related to structural impairments. These deter-
mined a significant potential of dark-field radiography
and computed tomography (CT) for the detection of
structural pulmonary diseases [31–42]. A further
important step towards clinics was the development of
x-ray dark-field systems allowing imaging studies of the
lung of larger animals and human bodies [17, 43–46].
Beyond the lung, the internal structure of bones was also
recognised to be a source of dark-field signal [47, 48].
One study [43] presented full body x-ray dark-field and
transmission images of a euthanised pig. The authors
found strong dark-field signal in the lung as well as in
some skeleton structures.
We present transmission and dark-field images cover-
ing the majority of a human body. We compare the
signal strengths of both types of images for different
body regions and discuss the detectability of anomalies
on both image modalities. Furthermore, the effect of
beam hardening on dark-field images is discussed by




The three-grating setup has been previously described
[44–46]. The source grating (G0) had an area of 5.0 ×
2.5 cm2, a period of 68.72 μm, and a duty cycle of 0.7.
The other two gratings (G1: period 8.73 μm, duty cycle
0.5, G2: period 10 μm, duty cycle 0.5) were created from
eight tiles, each with a size of 5.0 × 2.5 cm2, to achieve a
total size of 40 × 2.5 cm2 per grating, as already
described by Schröter et al. [49]. The G0–G1 and the
G1–G2 distances were 1.60 and 0.25 m, respectively. All
gratings were gold-filled attenuation gratings (gold filling
height of 150–200 μm) provided by Karlsruhe Institute
of Technology (Karlsruhe, Germany) and Microworks
GmbH (Karlsruhe, Germany). For this highly asymmet-
ric configuration, the immediate shadow of G1 instead of
the Talbot effect was exploited to generate an intensity
pattern at the position of G2. A similar approach was
already described [50]. All gratings are mounted on a
common frame pivoted about an axis through the
source’s focal spot. An effective field of view of 32 × 35
cm2 was achieved (in the object plane, 10 cm above the
sample table) by scanning the grating frame across the
detector. Source, detector and sample remain stationary
during the acquisition. Acquisition time was 40 s per
scan. The x-ray source (Philips MRC 200 0310 ROT GS,
Philips Medical Systems, Hamburg, Germany) was oper-
ated at 70 kVp and 700 mA for the whole-body
measurement.
Data acquisition and processing
For the acquisition of the individual images, a moiré
fringe-scanning method was used [17, 51]. By introdu-
cing a slight mismatch of the distance between modula-
tion grating and analyser grating, a low-frequency fringe
pattern is generated in the detector plane, representing
the relative lateral positions of modulation and analyser
grating structures. This pattern is scanned over each
sample point via movement of the grating frame, gener-
ating a series of images. In this way, a moiré pattern is
sampled for each detector pixel, and a method similar to
the more common, so-called phase-stepping acquisition
procedure [8, 17] can be used to retrieve mean intensity
As, interferometric visibility Vs (i.e., the relative contrast
of the fringe pattern), and lateral phase shift φs of the
pattern. Repeating the procedure without a sample yields
the reference values Ar, Vr, and φr, allowing the
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calculation of attenuation α = − ln (As/Ar) and visibility
reduction ν = − ln (Vs/Vr) of the sample.
Since a visibility reduction due to beam hardening
occurs in areas with high attenuation, a correction
method, adapted from Pelzer et al. [52], was used to
rectify the dark-field signal: transmission Tk and visibility
reduction νk signals were measured for several polyoxy-
methylene (POM) plastic heights hk. A reference curve
νBH(T), which indicates visibility reduction as a function
of transmission, was calculated from these points. The
corrected dark-field signal D of a sample is then given
by D = ν − νBH. POM was chosen as a reference material
for soft tissue and fat in the visibility reduction calibra-
tion as it has similar spectral attenuation properties as
soft tissue and fat.
The transmission and dark-field images of the human
body were combined from six individual scans, leading
to a total scanned area of 177 × 30 cm2 in the patient
plane. The body was placed on a motorised sample table.
The upper body was imaged in three scans, and the scan
range was selected by adjusting the table position before
each scan. Due to the table limited movement range, the
body was then rotated by 180° to allow imaging the
lower body. Three additional scans were acquired in this
orientation.
Human cadaver
The experiment was approved by the institutional review
board (Ethikkommission der Ludwig-Maximilians-
Universität München, Pettenkoferstraße 8a, 80336 Mun-
ich, Germany) and was conducted according to the Dec-
laration of Helsinki. The full-body radiographs were
taken from a 62-year-old female body (height 162 cm,
weight 49 kg). Images were taken 4 days postmortem,
and the lung was ventilated by an anaesthesia machine
(Fabius® Tiro, Drägerwerk AG & Co. KGaA, Lübeck,
Germany) with a constant pressure of 18 mbar.
Dose estimation
The dose area product was estimated from the incident
air kerma, measured with a PTW NOMEX dosimeter
(PTW, Freiburg, Germany) and the area of the organ.
With this, the effective dose (ED) for different organs
can be calculated using conversion factors given by Wall
et al. [53].
Fig. 1 Attenuation (window level 2.5, window width 5) (a) and x-ray
dark-field (window level 0.175, window width 0.35) (b) radiographs
of a human cadaver excluding the arms, recumbent, anteroposterior
acquisition with the right hand side of the body on the left side. The
images are created from six individual scans. A correction for
visibility reduction due to beam hardening was applied
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Beam hardening measurements
In the experiment determining the effect of beam hard-
ening on the x-ray dark-field signal, different heights of
POM, aluminium, and neoprene were measured in a
phantom experiment as well as an ex situ pig lung
obtained from a local butcher. For the values of alumin-
ium, POM and neoprene, the transmission and dark-
field signal was calculated from the mean signal across a
region of interest of 22 × 47 mm2 for each material
height. The pig lung was ventilated with a pressure of 25
mbar. Each point in the provided scatter plot corre-
sponds to a value pair (T, ν) of one pixel in the two
(registered) images (see Fig. 4).
Data presentation
Data are given as simple point values or estimation or as
mean ± standard deviation.
Results
Full-body transmission and dark-field images of a
human body are shown in Fig. 1. These images were
combined from six individual scans. Figures 2 and 3
show transmission and dark-field radiographs of the hip
and the thigh regions with a narrower windowing in
order to highlight features in these regions.
For different organs, a rough estimation of ED is given
in Table 1. For comparison, typical ED reference values
as reported by Wall et al. [53] are presented for these
organs. The ED values for the chest, knee, and feet were
a lot higher than the typical ED values, whereas the ED
values for the head, abdomen, and pelvis were in the
range of the typical ED values.
The inflated lungs exhibit high transparency in the
attenuation image. In the dark-field image, both lungs
reveal a high signal (0.25 ± 0.13). The highest signal
intensity was seen in the lower lobe of the right lung
with 0.34. Conversely, low transmission signal and no
dark-field signal are observed in the abdominal region.
Bony structures are visible in the attenuation as well as
in the dark-field images. The mean dark-field signal of
the bones was 0.08 ± 0.06, with a maximum of 0.23 in
the cortical bone of the upper left leg. In particular, an
increased signal in both modalities occurs in the hip
joints, where anatomical changes due to osteoarthritis
are present (see Fig. 2). Furthermore, the right leg pre-
sents the result of osteosynthesis following a fracture of
the right femur. The fracture itself is not visible any-
more, which correlates nicely with the CT image, where
the complete healing of the fracture can be confirmed.
In contrast, the metal screws and plate are clearly visible.
In addition, an antibiotic bead chain, which is still in
situ, is clearly visible in the dark-field image (0.30 ±
0.02). With respect to vascular structures, the calcifica-
tion of the femoral arteries can be clearly depicted in
both the upper legs in all three modalities (see Fig. 3).
Finally, in soft tissue, barely any dark-field signal can be
observed (0.023 ± 0.019).
Figure 4 shows a plot of uncorrected visibility reduc-
tion ν = −ln (Vs/Vr) versus the corresponding attenuation
signal α = − ln (As/Ar) of each measured phantom ma-
terial (i.e., aluminium, POM, neoprene and an ex situ pig
lung). It is apparent that the visibility reduction signal of
the lung and neoprene increases more steeply as a func-
tion of the transmission signal than that of aluminium.
Among all measured materials, the visibility reduction
Fig. 2 Conventional x-ray (window level 4.05, window width 1.1) (a) and dark-field radiograph (window level 0.8, window width 2.0) (b), and
coronal computed tomography reconstruction (c) of the pelvic region. The red arrows mark an area with subchondral sclerosis as a cause of
bilateral osteoarthritis of the hips. These areas exhibit an increased signal at both modalities. Whereas the increased attenuation signal is due to
the associated thickening of the bone structure, the increased dark-field signal can be attributed due to spectral hardening effects as well as
increased small-angle scatter
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signal of POM increases the least with α. For POM and
aluminium, the transmission signal increases as well as
the visibility reduction, even though these objects do not
produce small-angle scatter. The increase of visibility re-
duction is stronger for aluminium than for POM.
Discussion
In past small animal studies, x-ray dark-field imaging
showed a potential benefit in diagnosing lung diseases
[31–42, 54]. Subsequent large animal and human
cadaver measurements showed the possibility to trans-
late x-ray dark-field radiography to the human scale
[43–46], and a first study on dark-field chest radiographs
of human bodies showed that the dark-field signal could
be reliable quantified [55]. However, further applications
of x-ray dark-field imaging has not been extensively
investigated on large animal models or human cadavers
yet.
In this study, we presented the first x-ray dark-field
image of a complete human body and compared findings
in the transmission, dark-field and CT images. A high
dark-field signal was found in the lung. Furthermore, the
bone, calcification in the femoral arteries, implants and
foreign bodies also produce a dark-field signal. Phantom
measurements showed that a strong visibility reduction
signal can be produced by objects which do not generate
small-angle scatter.
In this study, the ED values resulted to be higher than
typical ED in some organs. The typical ED are given for
radiographs where only the organ in question is imaged.
As a consequence, image parameters like tube current
were chosen to be optimal for imaging this organ. In our
study, the imaging parameters were the same for all or-
gans. Thus, the tube current had to be chosen in such a
way that enough photons reach the detector behind the
more absorbing body parts like head, pelvis, and abdo-
men. For those regions, the ED in this study resulted to
be similar to the typical ED. Higher ED in less absorbing
organs is a consequence of this experimental setup.
Our results concerning the thorax region are similar
to the results reported in other studies [43, 44, 46]. The
considerable dark-field signal in the lung originates from
small-angle scattering on the numerous air-tissue inter-
faces in the lung parenchyma, whereas the high trans-
mission is due to the weak attenuation of the mainly air-
filled lungs. In this study, the dark-field signal of the
lung was lower compared to the dark-field signal of the
pig lung reported by Hauke et al. [43]. The authors
euthanised a pig a few minutes before image acquisition,
whereas in this study, the images were taken 4 days
postmortem. Therefore, the lung of the human body was
more strongly collapsed with partially fluid-filled alveoli
compared to the pig lung and not as many air-tissue
interfaces were present anymore in the human lung.
Fig. 3 X-ray attenuation (window level 2.45, window width 1.9) (a), dark-field (window level 0.4, window width 2.0) (b) radiographs, and a
computed tomography reconstruction (c) of the upper legs. The metal screws and plate on the right femur, a fixation of an old fracture, are
clearly visible in all three modalities. Near the screws, an antibiotic bead chain is also visible in the attenuation and dark-field images (red arrows).
Furthermore, calcifications are visible within the superficial femoral arteries in both thighs at all three modalities (green arrows)
Table 1 Rough estimation of effective dose in the study and
literature values for different organs
Organ ED (mSv) Typical ED (mSv)a ED/typical ED
Head AP 0.034 0.033 1.03
Chest PA 0.268 0.014 19.14
Abdomen AP 0.300 0.430 0.70
Pelvis AP 0.220 0.280 0.79
Femur AP 0.051 0.011 4.64
Knee AP 0.004 0.0001 40.00
Feet oblique 0.0024 0.0001 24.00
AP Anteroposterior, PA Posteroanterior, ED Effective dose
aWall et al. [53]
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In contrast to the lungs, barely any air-tissue interfaces
exist in the stomach and, as a consequence, no dark-
field signal originates in the stomach. The low attenu-
ation signal is a result of the stomach being extensively
filled with air due to a previous incorrect positioning of
the endotracheal tube within the oesophagus.
Dark-field signal is generated by the individual beads
of the antibiotic bead chain, as these are made from a
spongious material which acts as a substrate for the anti-
biotic agent. Spongious materials contain large numbers
of interfaces with air, leading to an increase in scattering
and therefore to an increased dark-field signal.
Calcification, i.e., accumulation of calcium salt, in particu-
lar of arterial walls (as it can be seen in atherosclerosis), is a
common finding, especially in patients with cardiovascular
risk factors. Atherosclerosis can lead to stenosis of the af-
fected arteries, resulting in hypoperfusion of the anatomical
region which is supplied by the respective artery. Depend-
ing on the affected arteries, patients can suffer from coron-
ary or peripheral artery disease, as it was for the patient in
our study. Previous studies showed that calcification in the
breast is visible in the dark-field image, potentially improv-
ing breast cancer detection [56–58]. We were also able to
see calcification of the arteries in the dark-field image.
However, whether the calcification is better and earlier vis-
ible on dark-field than common transmission images and if
dark-field imaging has the potential to improve the diag-
nostic value has to be determined in further studies.
Bony structures are visible in both transmission and
dark-field images, especially the areas of increased cal-
cium content: subchondral sclerosis as a cause of bilat-
eral osteoarthritis of the hips was highly visible in the
dark-field image. Similarly, subchondral sclerosis due to
osteoarthritis of both knees also resulted in a high signal
on the dark-field images.
As visible in Fig. 4, even non-scattering materials can
cause a reduction in visibility which is due to beam
hardening. The interferometric visibility of an x-ray
dark-field imaging setup is not only dependent on the
setup arrangement (i.e., grating periods and inter-grating
distances), but also on the spectrum of the x-ray beam.
In our setup, visibility was high for photon energies up
to 40 keV and decreases continuously for higher ener-
gies. When measuring with energy integrating detectors,
the average visibility results from the detector signal of
the energy dependent visibility weighted with the de-
tected signal from each photon energy [59]. Since the
low-energy x-rays, which contribute the most to the
measured visibility, are preferentially attenuated by most
materials, the measured, average visibility decreases. As
a result, non-scattering, strongly attenuating materials
can induce a decrease of visibility, which is
Fig. 4 Effect of beam hardening and small-angle scattering on the x-ray dark-field signal. Measured with 1, 2, 4, 8, and 16 mm of aluminium; 3, 5,
7, 9, and 11 cm of polyoxymethylene (POM); 1, 2, 3, and 4 cm of neoprene and an ex situ pig lung. Although no scattering object was in the
beam path during the measurement of POM and aluminium, an apparent dark-field signal was generated by beam hardening. Aluminium
exhibits similar spectral attenuation properties as the bone, whereas POM more closely approximates soft and adipose tissue. The large
discrepancy between the two curves explains the strong apparent dark-field signal due to the bones in Figs. 1, 2, and 3, despite application of a
POM-based beam hardening correction
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indistinguishable from a true dark-field signal due to
small-angle x-ray scatter. For soft and adipose tissues,
this effect could largely be eliminated by a correction,
which is based on visibility reduction measurements of
POM. As POM has spectral attenuation properties simi-
lar to soft tissue, which differs significantly from those of
bone and metal, the correction however fails to
accurately model their contribution to beam hardening,
and a residual visibility reduction signal remains.
It has been shown that the bones also generate a dark-
field signal [47, 48, 60]. The dark-field signal of the
bones is lower as the signal of the lungs. Our setup
showed a lower sensitivity than the ones used for bone
measurements. Therefore, in our opinion, the dark-field
signal of the bones in the here presented measurements
mainly result from residual visibility reduction signal.
Our study has some limitations. First, only one human
body was imaged. Furthermore, the complete image was
stitched together from six individual scans and the body
had to be repositioned during the acquisition procedure.
This experimental setup is not practical as an imaging
approach in clinical routine. This problem could be
overcome by changing the acquisition of the dark-field
images: instead of moving the interferometer, the sample
could be moved as proposed by Seifert et al. [61]. Thus,
the patient can be imaged in one scan similar to a full
body CT scan. Lastly, the beam hardening correction
was performed with respect to the soft tissue compo-
nent. Removal of beam-hardening-related artefact
depends on the knowledge of the material composition
of the body part in question. Calibration data and algo-
rithms used for correction must therefore be tailored to
the measured body part. In particular, superposition of
materials with very different spectral properties (e.g.,
bone and soft tissue) presents a special challenge for
beam-hardening-related visibility correction in dark-field
radiography, since the individual material contributions
to the total attenuation cross-section along the x-ray
path are unknown and vary over the field of view. A use-
ful approach in such a case may be to use dual-energy
acquisition, which may allow calculating spatial maps of
such cross-section fractions and thus enabling correction
of beam-hardening-related dark-field artefact for two
different materials.
In conclusion, we gave an overview over the dark-field
signal strength of different organs of the human body
presenting images and data from a female cadaver. How-
ever, before dark-field imaging can be included into the
clinical routine, further studies will have to be con-
ducted. Besides lung imaging, bone imaging and the pos-
sibility of diagnosing calcification might be of special
interest.
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